Evidence map›Paper›PMID 35458453›Full record

ArticleViruses2022

Plasma Total Antioxidant Capacity and Carbonylated Proteins Are Increased in Pregnant Women with Severe COVID-19.

Juan Mario Solis-Paredes, Araceli Montoya-Estrada, Adriana Cruz-Rico, Enrique Reyes-Muñoz, Javier Perez-Duran, Salvador Espino Y Sosa, Victor Ranferi Garcia-Salgado, Rosalba Sevilla-Montoya, Raigam Jafet Martinez-Portilla, Guadalupe Estrada-Gutierrez and 6 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Impact of Severe COVID-19 on Plasma Antioxidants.Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Juan Mario Solis-ParedesClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0003-4529-8296
Araceli Montoya-EstradaCoordination of Gynecological and Perinatal Endocrinology, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0001-5057-2793
Adriana Cruz-RicoCoordination of Gynecological and Perinatal Endocrinology, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.
Enrique Reyes-MuñozCoordination of Gynecological and Perinatal Endocrinology, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0001-5304-7476
Javier Perez-DuranClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.
Salvador Espino Y SosaClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0001-7276-8463
Victor Ranferi Garcia-SalgadoClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.
Rosalba Sevilla-MontoyaClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.
Raigam Jafet Martinez-PortillaClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0003-4711-3857
Guadalupe Estrada-GutierrezClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0001-9551-9021
Juan Alexander Gomez-RuizMaternal-Fetal Medicine Department, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.
Paloma Mateu-RogellClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0002-5677-5572
Jose Rafael Villafan-BernalLaboratory of Immunogenomics and Metabolic Diseases, Instituto Nacional de Medicina Genomica, Mexico City 14610, Mexico.
Lourdes Rojas-ZepedaMaternal Fetal Medicine Department, Instituto Materno Infantil del Estado de México, Toluca 50170, Mexico.
Maria Del Carmen Perez-GarciaObstetrics & Gynecology Resident, Instituto Nacional de Perinatología, Mexico City 11000, Mexico.
Johnatan Torres-TorresClinical Research Branch, Instituto Nacional de Perinatologia, Mexico City 11000, Mexico.ORCID 0000-0002-9524-4133
Instituto Nacional de Perinatología · MXHospital General de México · MXInstituto de Salud del Estado de México · MXNational Institute of Genomic Medicine · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress (OS) induced by SARS-CoV-2 infection may play an important role in COVID-19 complications. However, information on oxidative damage in pregnant women with COVID-19 is limited. Objective: We aimed to compare lipid and protein oxidative damage and total antioxidant capacity (TAC) between pregnant women with severe and non-severe COVID-19. Methods: We studied a consecutive prospective cohort of patients admitted to the obstetrics emergency department. All women positive for SARS-CoV-2 infection by reverse transcription-polymerase chain reaction (RT-qPCR) were included. Clinical data were collected and blood samples were obtained at hospital admission. Plasma OS markers, malondialdehyde (MDA), carbonylated proteins (CP), and TAC; angiogenic markers, fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF); and renin-angiotensin system (RAS) markers, angiotensin-converting enzyme 2 (ACE-2) and angiotensin-II (ANG-II) were measured. Correlation between OS, angiogenic, and RAS was evaluated. Results: In total, 57 pregnant women with COVID-19 were included, 17 (28.9%) of which had severe COVID-19; there were 3 (5.30%) maternal deaths. Pregnant women with severe COVID-19 had higher levels of carbonylated proteins (5782 pmol vs. 6651 pmol; p = 0.024) and total antioxidant capacity (40.1 pmol vs. 56.1 pmol; p = 0.001) than women with non-severe COVID-19. TAC was negatively correlated with ANG-II (p < 0.0001) and MDA levels (p < 0.0001) and positively with the sFlt-1/PlGF ratio (p = 0.027). Conclusions: In pregnant women, severe COVID-19 is associated with an increase in protein oxidative damage and total antioxidant capacity as a possible counterregulatory mechanism.

Indexed as

COVID-19AntioxidantsFemaleHumansPlacenta Growth FactorPregnancyPregnant PeopleProspective StudiesSARS-CoV-2Vascular Endothelial Growth Factor Receptor-1AntioxidantsPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1carbonylated proteinspregnancysevere COVID-19total antioxidant activity

Identifiers

PMID35458453
PMCPMC9025616
OpenAlexW4221040938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.